![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Kyongbo Pharmaceutical Co., Ltd. Asan-si Kr, based in South Korea, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Cefotaxime sodium, Sterile, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2006-224 - Rev 04
This Chemical Type CEP, issued on July 12, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 989 associated with this CEP further emphasizes